Search research articles
Contact Us
Filters
Showing results (31-40 of 42) with videos related to
Page
of 5
Sort By:
Bioanalysis
|
July 22, 2014
Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact
Suzanna M Tatarewicz, Daniel T Mytych, Marta Starcevic Manning, et al.
The AAPS Journal
|
October 12, 2012
Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics
Lei Zhou, Sarah A Hoofring, Yu Wu, et al.
Clinical Chemistry
|
November 22, 2005
Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies
Michael Moxness, Suzanna Tatarewicz, Dohan Weeraratne, et al.
Annals of Hematology
|
February 16, 2010
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
Vibha Jawa, Martha Hokom, Zheng Hu, et al.
Bioanalysis
|
May 7, 2013
Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates
Sarah A Hoofring, Rocio Lopez, M Benjamin Hock, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab
James A Lofgren, Sripriya Dhandapani, Jason J Pennucci, et al.
Journal of Immunological Methods
|
February 20, 2007
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
Shalini Gupta, Stephen R Indelicato, Vijay Jethwa, et al.
Journal of Immunological Methods
|
May 29, 2012
Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing
Daniel T Mytych, Troy E Barger, Chadwick King, et al.
Cancer Treatment Reviews
|
August 31, 2025
Interpreting immunogenicity in oncology clinical trials
Peter R Galle, Martin Reck, David J Pinato, et al.
BMC Clinical Pharmacology
|
November 11, 2011
Immunogenicity of panitumumab in combination chemotherapy clinical trials
Dohan Weeraratne, Alin Chen, Jason J Pennucci, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 42) with videos related to
Sort By:
Page
of 5
Bioanalysis
|
July 22, 2014
Strategic characterization of anti-drug antibody responses for the assessment of clinical relevance and impact
Suzanna M Tatarewicz, Daniel T Mytych, Marta Starcevic Manning, et al.
The AAPS Journal
|
October 12, 2012
Stratification of antibody-positive subjects by antibody level reveals an impact of immunogenicity on pharmacokinetics
Lei Zhou, Sarah A Hoofring, Yu Wu, et al.
Clinical Chemistry
|
November 22, 2005
Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies
Michael Moxness, Suzanna Tatarewicz, Dohan Weeraratne, et al.
Annals of Hematology
|
February 16, 2010
Assessment of immunogenicity of romiplostim in clinical studies with ITP subjects
Vibha Jawa, Martha Hokom, Zheng Hu, et al.
Bioanalysis
|
May 7, 2013
Immunogenicity testing strategy and bioanalytical assays for antibody-drug conjugates
Sarah A Hoofring, Rocio Lopez, M Benjamin Hock, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 22, 2007
Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab
James A Lofgren, Sripriya Dhandapani, Jason J Pennucci, et al.
Journal of Immunological Methods
|
February 20, 2007
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
Shalini Gupta, Stephen R Indelicato, Vijay Jethwa, et al.
Journal of Immunological Methods
|
May 29, 2012
Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing
Daniel T Mytych, Troy E Barger, Chadwick King, et al.
Cancer Treatment Reviews
|
August 31, 2025
Interpreting immunogenicity in oncology clinical trials
Peter R Galle, Martin Reck, David J Pinato, et al.
BMC Clinical Pharmacology
|
November 11, 2011
Immunogenicity of panitumumab in combination chemotherapy clinical trials
Dohan Weeraratne, Alin Chen, Jason J Pennucci, et al.
Page
of 5